| Gögenur, Ismail |
NEOLAR, NCT03280407: NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 124 | Europe | Capecitabine, FOLFOX regimen (oxaliplatin/leucovorin/5FU), FOLFOX (oxaliplatin/leucovorin/5FU), CAPOX (oxaliplatin/capecitabine) | Zealand University Hospital | Colorectal Neoplasm, Colorectal Cancer, Rectal Neoplasms, Chemotherapy Effect, Intestinal Disease, Intestinal Neoplasms, Rectal Cancer | 12/18 | 12/24 | | |
MEFO, NCT04312360: Preoperative Endoscopic Treatment With Fosfomycin and Metronidazole in Patients With Right-sided Colon Cancer and Colon Adenoma (-trial) |
|
|
| Completed | 2 | 28 | Europe | therapeutic endoscopy with metronidazole and fosfomycin disodium | Zealand University Hospital, Costerton Biofilm Center, Reponex Pharmaceuticals A/S, Region Zealand | Right-sided Colon Cancer, Right-sided Colon Adenoma | 04/22 | 07/23 | | |
| Terminated | 2 | 9 | Europe | Nivolumab, Opdivo, Irreversible electroporation (IRE) | Ismail Gögenur | Pancreas Cancer | 08/23 | 08/23 | | |
| Active, not recruiting | 2 | 21 | Europe | Melatonin, Placebo | Ismail Gögenur, Hvidovre University Hospital, Aarhus University Hospital | Low Anterior Resection Syndrome | 12/23 | 12/23 | | |
| Recruiting | 2 | 48 | Europe | 5Fluorouracil, Imiquimod, Melatonin | Ismail Gögenur | Actinic Keratoses | 02/24 | 12/24 | | |
IMPULS, NCT06145074: Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC. |
|
|
| Recruiting | 2 | 30 | Europe | Propranolol, Inderal, Propal, Placebo, Inactive drug | Zealand University Hospital, Rigshospitalet, Denmark | Pancreatic Cancer, Surgery | 12/26 | 12/35 | | |
| Completed | 2 | 85 | Europe | Pembrolizumab, Keytruda | Camilla Qvortrup, Zealand University Hospital, Odense University Hospital, Vejle Hospital, Herlev and Gentofte Hospital, Bispebjerg Hospital, Aalborg University Hospital, Horsens Hospital, Randers Regional Hospital, Aarhus University Hospital | Colon Cancer | 06/24 | 06/24 | | |
IPOS, NCT04798612: Effect of Low-dose Interferon-alfa2a on Peri-operative Immune Suppression |
|
|
| Recruiting | 2 | 68 | Europe | Pegasys, Saline | Zealand University Hospital, University of Copenhagen | Colon Cancer | 08/25 | 12/25 | | |
| Terminated | 2 | 4 | Europe | Irreversible electroporation, (IRE), Calcium electroporation, (CaEP), Pembrolizumab, Keytruda | Ismail Gögenur | Metastatic Colorectal Cancer | 04/24 | 05/24 | | |
NCT04816045: Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial |
|
|
| Not yet recruiting | 1/2 | 24 | NA | Electrochemotheraoy, Electroporation with saline (placebo) | Zealand University Hospital | Colorectal Cancer | 07/23 | 12/23 | | |
NCT04979832: GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery |
|
|
| Recruiting | 1/2 | 18 | Europe | GM-CSF, fosfomycin and metronidazole, GM-CSF, Fosfomycin, Metronidazole | Zealand University Hospital | Pouchitis | 12/23 | 12/23 | | |
| Active, not recruiting | N/A | 12 | Europe | Colorectal cancer surgery | University of Copenhagen, Zealand University Hospital | Colorectal Cancer, Surgery | 12/19 | 06/23 | | |
| Recruiting | N/A | 115 | Europe | Quantitative Indocyanine Green Fluorescence Angiography | Zealand University Hospital, Perfusion Tech Aps | Colorectal Cancer, Anastomotic Leak | 08/24 | 08/24 | | |
NCT03637686: IMPROVE: Circulating Tumor DNA Analysis to Optimize Treatment for Patients With Colorectal Cancer |
|
|
| Active, not recruiting | N/A | 3182 | Europe | | University of Aarhus, Aarhus University Hospital | Colorectal Cancer | 07/28 | 07/28 | | |
